^{_{Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.}}

0830 - Building permits for July: Expected 1.385M; Prior 1.393M
0830 - Housing starts for July: Expected 1.297M; Prior 1.321M
1410 - Fed’s Bowman speaks

Intel Corp (INTC)

+5.66%

Gapping up after announcing that SoftBank agreed to invest $2 billion in the company through a primary stock issuance at $23 per share, giving it just under a 2% stake. The move comes as the Trump administration reportedly considers taking a 10% stake in Intel. This stake also highlights SoftBank’s broader 2025 investment spree, including major bets on OpenAI and the $500 billion Stargate data center project.

Palo Alto Networks Inc (PANW)

+5.98%

Gapping up following its Q4 2025 earnings report, with adjusted earnings of $0.95 per share and sales of $2.536 billion beating estimates of $0.88 and $2.502 billion, respectively. The company guided adjusted earnings between $0.88 and $0.90 per share for Q1 2026, beating estimates of $0.85, and its sales guide of $2.45 billion to $2.47 billionfor the same quarter similarly beat estimates of $2.43 billion. Palo Alto also projected stronger-than-expected earnings and revenue for fiscal 2026.

NVIDIA Corp (NVDA)

+0.11%

On watch after Reuters reported that the company is developing a new AI chip for China. The chip, tentatively called the B30A, will reportedly be more powerful than its current H20 model and incorporate its latest Blackwell architecture in a single-die design with high-bandwidth memory and NVLink. This chip could reach Chinese clients for testing as early as next month, but U.S. regulatory approval remains uncertain. Separately, Morgan Stanley asserted that Nvidia is the most under-owned stock in the megacap tech space after analyzing 13F filings for Q2 2025.

Ethereum Stocks

-1.42%

Trading lower as a group amid weakness in the the crypto space, with both Bitcoin and Ethereum poised to post back-to-back losing sessions. Ethereum opened Monday’s session near the $4,800 level but sold off throughout the day, reaching a low around $4,220 before closing at $4,315. The cryptocurrency is continuing to trade near the $4,300 level as of Tuesday morning at 7:15 AM but has reached lows below $4,200 on the session thus far.

ETHA, ETHE, SBET, BMNR

Tesla Inc (TSLA)

-0.28%

The company has begun taking orders in China for its new Model Y L, priced from $47,184, as part of a lineup refresh to counter rising competition in the world’s largest EV market. The launch follows earlier updates to the Model Y and plans for a longer-range Model 3. Separately, analysts from William Blair said Tesla’s Austin robotaxi trial demonstrated strong pricing power, with fares about half of Uber’s and operating costs far below Waymo’s.

Novo Nordisk A/S (NVO)

+1.92%

The company announced that Health Canada has approved Ozempic to reduce the risk of kidney failure, disease progression, and cardiovascular death in type 2 diabetes patients with chronic kidney disease. This makes Ozempic the first treatment in Canada cleared for both diabetes management and slowing kidney disease progression, following similar US approval earlier this year.

Xpeng Inc (XPEV)

+4.92%

Trading higher premarket following its Q2 2025 earnings report. The company reported adjusted losses of $0.06 per American depository share, an improvement from the $0.18-per-ADS loss reported in Q2 2024, with sales of $2.55 billion similarly improving on a year-over-year basis. Xpeng delivered 103,181 vehicles in Q2 2025, marking a 241.6% year-over-year increase, and expects Q3 deliveries to improve by 142.8% to 143.6% year-over-year. The company guided Q3 sales between $2.736 billion and $2.931 billion, compared to estimates of $2.81 billion.

Medtronic PLC (MDT)

-3.03%

Trading lower premarket following its Q1 2026 earnings report. Adjusted earnings of $1.26 per share beat estimates of $1.23, and sales of $8.578 billion beat estimates of $8.378 billion. The company raised its EPS and sales guidance for fiscal 2026 to $5.60-$5.66 and $35.72 billion-$35.82 billion, respectively, exceeding analyst estimates. Medtronic also announced updates to its board and noted plans to host an investor day in 2026; these changes were attributed to “constructive engagement” with activist investor Elliott Management.

Home Depot Inc (HD)

+1.09%

Trading marginally higher premarket following its Q2 2025 earnings report. Adjusted earnings of $4.68 per share and sales of $45.277 billion missed estimates of $4.71 and $45.356 billion, respectively. Comparable sales rose by 1% year-over-year, with US comparable sales increasing by 1.4%. The company maintained its adjusted EPS and GAAP EPS guidance for FY25, both of which missed analyst estimates, and continued to guide lower-than-expected sales for the fiscal year.

Palantir Technologies Inc (PLTR)

-0.78%

On watch after the company announced that it is expanding its partnership with Fujitsu through a new licensing deal. This will allow Fujitsu to offer the Palantir Artificial Intelligence Platform (AIP) in Japan, with global rollout plans later this fiscal year. The integration of AIP into Fujitsu’s Uvance framework and AI services will enhance generative AI applications across industries, improving efficiency, risk prediction, and Japanese-language functionality.

Viking Therapeutics Inc (VKTX)

-36.86%

Trading with heightened volatility in the premarket session after reporting Phase 2 results for its oral obesity drug VK2735. Patients lost up to 12.2% of body weight in 13 weeks compared to 1.3% weight loss with the placebo, with the top dosage showing high results. While GI-related side effects led to higher discontinuation, most were mild, and an exploratory arm suggested weight loss could be maintained with lower follow-up dosing. The drug is also in Phase 3 trials in injectable form.

Laser Photonics Corp (LASE)

+95.12%

Gapping up following its Q2 2025 earnings report. Revenue grew by 317% on a year-over-year basis to reach $2.599 million for the quarter, and quarterly losses tightened from $0.20 to to $0.12 year-over-year. Approximately 14.04% of the stock’s float is sold short.